Test Price
2,800 AED✅ Home Collection Available
BEAN1 Gene Spinocerebellar Ataxia Type 31 (SCA31) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity via ISO-Certified NGS processing in a DHA-licensed genomic facility at Dubai Healthcare City.
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Free DNA-stabilizing FTA card option included.
- Post-Test Clinical Guidance: Complimentary telephone-based result interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance Direct Billing: Instant verification and pre-approval via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Our BEAN1 Gene Spinocerebellar Ataxia Type 31 (SCA31) Genetic Test leverages next‑generation sequencing to detect pathogenic pentanucleotide repeat expansions and other variants in the BEAN1 gene with 99.9% analytical sensitivity, enabling definitive diagnosis and informed family planning. Delivered within 3–4 weeks from sample collection, the assay fully complies with DHA molecular diagnostics standards and operates in a UAE‑based, ISO‑certified laboratory at Dubai Healthcare City.
| Feature | Our Test (NGS) | Standard Sanger SCA31 Panel |
|---|---|---|
| Method | Next‑Generation Sequencing (Illumina) | Sanger sequencing (targeted repeat expansion) |
| Sensitivity | >99.9% for all pathogenic variants | ~95% for known pentanucleotide repeats |
| Turnaround | 3–4 weeks | 4–6 weeks (often international) |
| Sample Options | Blood, extracted DNA, FTA card | Blood or DNA (limited stability) |
| UAE DHA Compliance | Full DHA molecular diagnostics standards | Variable |
| Price (AED) | 2,800 | Often >3,000 + shipping |
Physician Insight & Safety Protocols
"This test offers powerful confirmation of SCA31, yet a positive result must always be correlated with detailed neurological examination and multi‑generational family history. I strongly recommend that every patient engage a certified genetic counsellor to fully grasp autosomal dominant inheritance patterns and potential reproductive choices. Remember, a gene mutation does not dictate your identity — many ataxia patients thrive with dedicated rehabilitation and community support."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
⚠️ Important Medication Advisory
Do not discontinue any prescribed neurological or psychiatric medication without prior consultation with your treating physician. Abrupt withdrawal may cause serious harm. Always consult your specialist before making any changes to your medication regimen.
Essential Safety Information – Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Inability to provide informed consent (or absent legal guardian as per UAE Federal Law)
- Active febrile illness that may compromise sample integrity
- Known coagulopathy with no medical clearance for venipuncture
- Minors without both parents' written authorization
Emergency Red Flags
- Sudden severe ataxia with loss of consciousness or head trauma
- Acute psychiatric distress or suicidal ideation triggered by genetic uncertainty
- Symptoms of stroke (facial droop, one‑sided weakness, speech difficulty)
- Severe allergic reaction after blood draw (rare anaphylaxis)
Patient FAQ & Clinical Guidance
1. What is the BEAN1 gene and how does it relate to SCA31?
BEAN1 (Brain Expressed, Associated with NEDD4) is a gene whose expanded pentanucleotide repeats lead to Spinocerebellar Ataxia Type 31, an autosomal dominant condition primarily seen in certain populations. The disease typically presents after age 50 with gait instability, dysarthria, and limb incoordination, although anticipation can lower the age of onset in successive generations. Our NGS test fully sequences the critical region to confirm or exclude the pathogenic repeat expansion.
2. How is the test performed and what sample is required?
We accept 2–3 ml of whole blood in an EDTA tube, extracted DNA, or a painless FTA card requiring just one drop of blood. Our trained phlebotomist visits your home at a scheduled time between 8 AM and 11 PM, and all samples are transported via validated temperature-controlled cold-chain to our ISO‑certified laboratory for NGS analysis on Illumina platforms. Turnaround time is 3–4 weeks, with a secure online report release.
3. What does a positive result mean for my family members?
Because SCA31 follows an autosomal dominant inheritance pattern, a positive result means that first‑degree relatives (children, siblings) have a 50% chance of carrying the same mutation. We strongly recommend cascade testing and formal genetic counseling before predictive testing of asymptomatic at‑risk relatives. UAE law mandates pre‑test counseling for minors, and we coordinate the entire process through our DHA‑licensed genetic counselor.
4. Is genetic counseling available before and after the test?
Yes, complimentary telephone-based genetic counseling is provided both before sample collection and after results are issued. Our Consultant Medical Geneticist, Lina Osama Zaki Quteineh (DHA License 9294403), personally reviews each case to ensure patients fully understand the implications of their results, including reproductive options and family planning strategies.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Genetic data is handled under strict data privacy controls and never shared without explicit patient consent.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: All electronic health records and genomic data transmission comply with UAE ICT health data security standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Patient safety, informed consent, and clinical accountability are fully governed under this framework.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139): International standard for laboratory quality management and continuous process improvement.
Clinical & Logistical Metadata
| Test Name | BEAN1 Gene Spinocerebellar Ataxia Type 31 (SCA31) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks from sample collection |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot) |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina platform with repeat expansion analysis |
| ICD-10-CM Code | G11.0 (Hereditary ataxia) |
| LOINC Code | 81247-9 (Spinocerebellar ataxia type 31 SCA31 BEAN1 gene repeat expansion analysis) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians